Eli Lilly Partners with Nvidia on AI Lab for Accelerated Drug Discovery
β’ Eli Lilly announced a collaboration with Nvidia to establish a co-innovation AI lab combining computing power with scientific expertise for faster drug discovery. β’ The partnership targets AI applications in identifying drug candidates, optimizing clinical trials, and reducing failure rates in biotech development. β’ This non-tech firm's AI push exemplifies how pharma giants are leveraging partnerships to lead in AI-driven innovation beyond traditional tech sectors.
barchart.com